advertisement
Tanito M 12
Showing records 1 to 12 |
Display all abstracts from Tanito M104438 Nation-Wide Analysis of Glaucoma Medication Prescription in Fiscal Year of 2019 in JapanTanito M
Journal of personalized medicine 2022; 12:
104362 Proportion of Glaucoma Types and Surgeries Among Young, Pre-Old, Old, and Oldest-Old Age Groups or Different Sex GroupsTanito M
Clinical Ophthalmology 2022; 16: 1815-1819
103835 Investigating the clinical usefulness of definitions of progression with 10-2 visual fieldAsano S
British Journal of Ophthalmology 2022; 106: 1098-1103
104424 Fingertip-Measured Skin Carotenoids and Advanced Glycation End Product Levels in GlaucomaKadoh Y
Antioxidants (Basel, Switzerland) 2022; 11:
103835 Investigating the clinical usefulness of definitions of progression with 10-2 visual fieldMurata H
British Journal of Ophthalmology 2022; 106: 1098-1103
104362 Proportion of Glaucoma Types and Surgeries Among Young, Pre-Old, Old, and Oldest-Old Age Groups or Different Sex GroupsMatsuoka Y
Clinical Ophthalmology 2022; 16: 1815-1819
104424 Fingertip-Measured Skin Carotenoids and Advanced Glycation End Product Levels in GlaucomaTakayanagi Y; Takayanagi Y
Antioxidants (Basel, Switzerland) 2022; 11:
103835 Investigating the clinical usefulness of definitions of progression with 10-2 visual fieldFujino Y
British Journal of Ophthalmology 2022; 106: 1098-1103
104424 Fingertip-Measured Skin Carotenoids and Advanced Glycation End Product Levels in GlaucomaSasaki J
Antioxidants (Basel, Switzerland) 2022; 11:
103835 Investigating the clinical usefulness of definitions of progression with 10-2 visual fieldYamashita T
British Journal of Ophthalmology 2022; 106: 1098-1103
104424 Fingertip-Measured Skin Carotenoids and Advanced Glycation End Product Levels in GlaucomaTanito M
Antioxidants (Basel, Switzerland) 2022; 11:
103835 Investigating the clinical usefulness of definitions of progression with 10-2 visual fieldMiki A; Ikeda Y; Mori K; Tanito M; Asaoka R
British Journal of Ophthalmology 2022; 106: 1098-1103
Issue 23-2
Change Issue
advertisement